14,883 Shares in The Procter & Gamble Company (NYSE:PG) Bought by V Square Quantitative Management LLC

V Square Quantitative Management LLC purchased a new position in The Procter & Gamble Company (NYSE:PGFree Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,883 shares of the company’s stock, valued at approximately $2,213,000. Procter & Gamble comprises about 2.0% of V Square Quantitative Management LLC’s portfolio, making the stock its 9th biggest holding.

A number of other institutional investors also recently made changes to their positions in PG. Axiom Financial Strategies LLC grew its position in shares of Procter & Gamble by 7.0% in the first quarter. Axiom Financial Strategies LLC now owns 1,728 shares of the company’s stock valued at $276,000 after purchasing an additional 113 shares during the period. AMI Investment Management Inc. grew its position in shares of Procter & Gamble by 7.2% in the first quarter. AMI Investment Management Inc. now owns 3,461 shares of the company’s stock valued at $529,000 after purchasing an additional 233 shares during the period. LSV Asset Management grew its position in shares of Procter & Gamble by 5.7% in the first quarter. LSV Asset Management now owns 18,600 shares of the company’s stock valued at $2,842,000 after purchasing an additional 1,000 shares during the period. Ergoteles LLC purchased a new stake in shares of Procter & Gamble in the first quarter valued at $3,073,000. Finally, Wsfs Capital Management LLC grew its position in shares of Procter & Gamble by 12.0% in the first quarter. Wsfs Capital Management LLC now owns 4,256 shares of the company’s stock valued at $650,000 after purchasing an additional 455 shares during the period. 64.65% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 4,852 shares of the company’s stock in a transaction that occurred on Wednesday, April 26th. The stock was sold at an average price of $155.47, for a total transaction of $754,340.44. Following the sale, the insider now owns 7,977 shares in the company, valued at $1,240,184.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CFO Andre Schulten sold 25,244 shares of the stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $155.27, for a total value of $3,919,635.88. Following the completion of the transaction, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at approximately $4,210,611.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Susan Street Whaley sold 4,852 shares of the stock in a transaction that occurred on Wednesday, April 26th. The stock was sold at an average price of $155.47, for a total value of $754,340.44. Following the completion of the transaction, the insider now directly owns 7,977 shares of the company’s stock, valued at $1,240,184.19. The disclosure for this sale can be found here. Insiders have sold 95,093 shares of company stock worth $14,821,930 over the last quarter. 0.26% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have recently commented on PG. Truist Financial downgraded Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price objective for the company from $165.00 to $155.00 in a research report on Thursday, May 18th. Evercore ISI boosted their price target on Procter & Gamble from $160.00 to $170.00 and gave the company an “outperform” rating in a research report on Monday, April 24th. StockNews.com assumed coverage on Procter & Gamble in a research report on Thursday, May 18th. They set a “buy” rating for the company. Raymond James boosted their price target on Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research report on Sunday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Procter & Gamble from $160.00 to $170.00 and gave the company a “buy” rating in a research report on Monday, April 24th. Five research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $161.50.

Procter & Gamble Trading Up 0.1 %

NYSE:PG opened at $148.93 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.39 and a current ratio of 0.59. The Procter & Gamble Company has a one year low of $122.18 and a one year high of $158.11. The business’s 50-day simple moving average is $149.82 and its 200 day simple moving average is $147.32. The stock has a market cap of $351.02 billion, a price-to-earnings ratio of 25.95, a price-to-earnings-growth ratio of 3.83 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, April 21st. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.32 by $0.05. Procter & Gamble had a return on equity of 32.18% and a net margin of 17.69%. The firm had revenue of $20.07 billion for the quarter, compared to analysts’ expectations of $19.32 billion. During the same quarter in the prior year, the firm posted $1.33 earnings per share. Procter & Gamble’s revenue for the quarter was up 3.5% compared to the same quarter last year. As a group, sell-side analysts predict that The Procter & Gamble Company will post 5.86 earnings per share for the current fiscal year.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.